Ferran Chuecos

407 citations

20 papers · 324 indexed · h-index 9

Pulmonary and Respiratory Medicine top 10%
Physiology top 10%
Immunology and Allergy
Emergency Medical Services
Issues, ethics and legal aspects top 10%

Co-authors: Esther García Gil Cynthia Caracta Dave Singh Robert Mróz Jutta Beier Anne‐Marie Kirsten Rosa Segarra Rosa Lamarca
Topics: Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers)Asthma and respiratory diseases (12 papers)Respiratory and Cough-Related Research (9 papers)
Cited by: Physiology Pulmonary and Respiratory Medicine Issues, ethics and legal aspects
Journals: European Respiratory Journal Thorax Respiratory Research
Partner nations: Spain United Kingdom United States

In The Last Decade

Ferran Chuecos

19 papers receiving 310 citations

Peers

Countries citing papers authored by Ferran Chuecos

Since Specialization

Citations

This map shows the geographic impact of Ferran Chuecos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferran Chuecos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferran Chuecos more than expected).

Fields of papers citing papers by Ferran Chuecos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferran Chuecos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferran Chuecos. The network helps show where Ferran Chuecos may publish in the future.

Co-authorship network of co-authors of Ferran Chuecos

This figure shows the co-authorship network connecting the top 25 collaborators of Ferran Chuecos. A scholar is included among the top collaborators of Ferran Chuecos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferran Chuecos. Ferran Chuecos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	<p>Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT</p> 2019 ·International Journal of COPD ·Anthony D’Urzo,Dave Singh,James F. Donohue,Edward Kerwin,Anna Feliu,Eduard Molins,Ferran Chuecos,Diana Jarreta,Esther García Gil	6
2	<p>An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD</p> 2019 ·International Journal of COPD ·Dave Singh,Anthony D’Urzo,James F. Donohue,Edward Kerwin,Eduard Molins,Ferran Chuecos,Anna Feliu,Diana Jarreta	17
3	Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol 2017 ·Respiratory Research ·Dave Singh,Anthony D’Urzo,Ferran Chuecos,(unknown),Esther García Gil	28
4	Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study 2017 ·International Journal of COPD ·Jutta Beier,Robert Mróz,Anne‐Marie Kirsten,Ferran Chuecos,Esther García Gil	7
5	Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy 2017 ·Dave Singh,Anthony D’Urzo,James F. Donohue,Edward Kerwin,Eduard Molins,Ferran Chuecos,(unknown),Diana Jarreta	1
6	The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis 2016 ·International Journal of COPD ·Marc Miravitlles,Kenneth R. Chapman,Ferran Chuecos,Anna Feliu,(unknown)	19
7	The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies 2016 ·Respiratory Research ·Paul Jones,Nancy Kline Leidy,Asha Hareendran,Rosa Lamarca,Ferran Chuecos,Esther García Gil	19
8	Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies 2016 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Jadwiga A. Wedzicha,Àlvar Agustí,Gavin C. Donaldson,Ferran Chuecos,Rosa Lamarca,Esther García Gil	8
9	Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials 2016 ·BMJ Open Respiratory Research ·Lorcan McGarvey,Alyn H. Morice,John A. Smith,Surinder S. Birring,Ferran Chuecos,Beatriz Seoane,Diana Jarreta	16
10	Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients 2015 ·Marc Miravitlles,Esther García Gil,Ferran Chuecos,Rosa Lamarca	2
11	Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity 2015 ·Anthony D’Urzo,Dave Singh,Edward Kerwin,Hassan Lakkis,Ferran Chuecos,Gonzalo de Miquel	3
12	Characterisation and impact of reported and unreported exacerbations: results from ATTAIN 2014 ·European Respiratory Journal ·Paul Jones,Rosa Lamarca,Ferran Chuecos,Dave Singh,Àlvar Agustí,Eric Bateman,Gonzalo de Miquel,Cynthia Caracta,Esther García Gil	62
13	The effect of twice-daily aclidinium bromide on cough and sputum in patients with COPD: Results from phase III studies 2014 ·Lorcan McGarvey,Alyn H. Morice,John A. Smith,Surinder S. Birring,Ferran Chuecos,Beatriz Seoane,Diana Jarreta	1
14	Effect of aclidinium bromide on exacerbations in patients with moderate-to-severe COPD: Pooled analysis of phase III studies 2014 ·Jadwiga A. Wedzicha,Gavin C. Donaldson,Ferran Chuecos,Esther García Gil	2
15	Improvement in COPD symptoms with aclidinium bromide vs placebo and tiotropium: A phase IIIb study 2013 ·European Respiratory Journal ·Jutta Beier,Anne‐Marie Kirsten,Robert Mróz,Rosa Segarra,Ferran Chuecos,Cynthia Caracta,Esther García Gil	2
16	Efficacy and safety of aclidinium bromide vs placebo and tiotropium in COPD: A phase IIIb study 2013 ·European Respiratory Journal ·Jutta Beier,Anne‐Marie Kirsten,Robert Mróz,Rosa Segarra,Ferran Chuecos,Cynthia Caracta,Esther García Gil	1
17	Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study 2013 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Jutta Beier,Anne‐Marie Kirsten,Robert Mróz,Rosa Segarra,Ferran Chuecos,Cynthia Caracta,Esther García Gil	87
18	S51 Efficacy of Aclidinium Bromide Compared with Tiotropium and Placebo in Patients with Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1 2012 ·Thorax ·Jutta Beier,Anne Kirsten,Robert Mróz,Rosa Segarra,Ferran Chuecos,Cynthia Caracta,Esther García Gil	3
19	Aclidinium Bromide, a Long-Acting Antimuscarinic, Does Not Affect QT Interval in Healthy Subjects 2010 ·The Journal of Clinical Pharmacology ·Kenneth C. Lasseter,(unknown),Ferran Chuecos,Esther García Gil	21
20	Meta-Analysis of the Efficacy of Ebastine 20 mg Compared to Loratadine 10 mg and Placebo in the Symptomatic Treatment of Seasonal Allergic Rhinitis 2005 ·International Archives of Allergy and Immunology ·Paul H. Ratner,(unknown),Ferran Chuecos,(unknown),Juan Domingo Gispert,Francesc Peris,(unknown),María J. Rosales	19

About Ferran Chuecos

Ferran Chuecos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services, having authored 20 papers that have together received 324 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (9 papers). The work is most often cited by research in Physiology (240 citations), Pulmonary and Respiratory Medicine (295 citations) and Issues, ethics and legal aspects (10 citations). Ferran Chuecos has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Esther García Gil, Cynthia Caracta, Dave Singh, Robert Mróz, Jutta Beier, Anne‐Marie Kirsten, Rosa Segarra, Rosa Lamarca, Paul Jones and Anthony D’Urzo. Their work appears in journals such as European Respiratory Journal, Thorax and Respiratory Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact